Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Common iliac vein

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44364   clinical trials with a EudraCT protocol, of which   7388   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    7 result(s) found for: Common iliac vein. Displaying page 1 of 1.
    EudraCT Number: 2005-004486-42 Sponsor Protocol Number: CaVenT Start Date*: 2006-01-03
    Sponsor Name:Eastern Norway Regional Health Authority [...]
    1. Eastern Norway Regional Health Authority
    2. Ullevaal University Hospital
    Full Title: Catheter-directed Venous Thrombolysis (CaVenT) in Acute Iliofemoral Vein Thrombosis - an open Randomized, Controlled, Clinical Trial
    Medical condition: Acute ilio-femoral vein thrombosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-001723-12 Sponsor Protocol Number: ARIVA_venous Start Date*: 2020-05-28
    Sponsor Name:Universitätsspital Zürich, Klinik für Angiologie
    Full Title: Aspirin® plus rivaroxaban versus rivaroxaban alone for the prevention of venous stent thrombosis in patients with post-thrombotic syndrome
    Medical condition: Post-thrombotic syndrome
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended) DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-002536-94 Sponsor Protocol Number: 1160.47 Start Date*: 2006-03-20
    Sponsor Name:Boehringer Ingelheim Finland Ky
    Full Title: A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2...
    Medical condition: Confirmed Venous Thromboembolism (VTE) i.e. uni or bilateral deep vein thrombosis (DVT) of the leg involving proximal veins and/or pulmonay embolism (PE) - treated with anticoagulant for 3 to 6 mo...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) AT (Completed) SE (Completed) CZ (Completed) BE (Completed) SK (Completed) GB (Completed) ES (Completed) DE (Completed) HU (Completed) PT (Completed) GR (Completed) DK (Completed) IT (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2007-006014-41 Sponsor Protocol Number: Vasovist MA-01 Start Date*: 2008-04-14
    Sponsor Name:University Heidelberg, University Hospital Mannheim
    Full Title: Determination of Diagnostic Accuracy and Added Value of Vasovist®-Enhanced Peripheral MRA in Comparison to Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients with Peripheral Arte...
    Medical condition: Patients suffering from PAOD stage III or stage IV (confirmed by ECCM MRA, CTA, non-selective DSA, DUS) and have an indication for the evaluation of the entire lower leg axis down to the feet (comm...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10002939 Aortoiliac occlusive disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-018141-20 Sponsor Protocol Number: IN0901INT Start Date*: 2010-06-30
    Sponsor Name:LEO Pharma A/S
    Full Title: Eficacia y Seguridad del Tratamiento a Largo Plazo (6 meses) con Innohep® frente a Anticoagulación con un Antagonista de la Vitamina K (Warfarina) para el Tratamiento del Tromboembolismo Venoso Agu...
    Medical condition: Tromboembolismo venoso (TEV) en pacientes con cáncer activo.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10066899 Venous thromboembolism LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) DE (Completed) SK (Completed) CZ (Completed) AT (Completed) PT (Completed) IT (Completed) DK (Completed) GR (Completed) LV (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2005-001999-12 Sponsor Protocol Number: 1160.53 Start Date*: 2006-03-14
    Sponsor Name:Boehringer Ingelheim Ltd.
    Full Title: A phase III, randomised, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6 month treatment of acute sy...
    Medical condition: Acute symptomatic venous thromboembolism (VTE), i.e. uni- or bilateral deep vein thrombosis (DVT) of the leg involving proximal veins, and/or pulmonary embolism (PE) confirmed by definitive objecti...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) FI (Completed) SE (Completed) DK (Completed) AT (Completed) BE (Completed) ES (Completed) HU (Completed) CZ (Completed) PT (Completed) GR (Completed) IT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-002631-86 Sponsor Protocol Number: 1160.46 Start Date*: 2008-10-23
    Sponsor Name:Boehringer Ingelheim Austia Gm.b.H
    Full Title: A phase III, randomised, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6 month treatment of acute sy...
    Medical condition: Acute symptomatic VTE VTE is defined as the composite incidence of Deep Vein Thrombosis of the leg (including the inferior caval vein) and Pulmonary Embolism.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037377 Pulmonary embolism LLT
    9.1 10047251 Venous thrombosis deep (limbs) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Completed) SK (Completed) ES (Completed) GB (Completed) NL (Completed) DK (Completed) CZ (Completed) SE (Completed) HU (Completed) FR (Completed) IT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Oct 26 01:44:37 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA